anti-GNRPX antibody product blog
Tags: Antibody; Polyclonal Antibody; GNRPX; anti-GNRPX antibody;
The GNRPX n/a (Catalog #MBS641234) is an Antibody produced from Goat and is intended for research purposes only. The product is available for immediate purchase. The GNRPX (Pleckstrin Homology Domain-containing Family J Member 1, PH Domain-containing Family J Member 1, Guanine Nucleotide-releasing Protein X, PLEKHJ1) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s GNRPX can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA).Suitable for use in ELISA.
Dilution: ELISA: 1:16,000. Researchers should empirically determine the suitability of the GNRPX n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The GNRPX n/a product has the following accession number(s) (GI #117616880) (NCBI Accession #ABK42458.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Synthetic peptide corresponding to C-SEEARFQLSGLQA, from PLEKHJ1, at C-terminal (NP_060519.1). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing GNRPX are readily searchable from our website. Different antibodies against the same target such as GNRPX may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.